About Peter F. Thall
Clinical Trial Design (2)
No Subject Area (4)
Simultaneously Optimizing Dose and Schedule of a New Cytotoxic Agent
The University of Michigan Department of Biostatistics Working Paper Series (2006)
Traditionally, phase I clinical trial designs determine a maximum tolerated dose of an experimental cytotoxic agent based on a fixed ...